Evidence map›Paper›PMID 18221754›Full record

ArticleJournal of molecular and cellular cardiology2008

Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair.

Ying Dai, Muhammad Ashraf, Shi Zuo, Ryota Uemura, Yan-Shan Dai, Yigang Wang, Husnain Kh Haider, Tingyu Li, Meifeng Xu

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction.American journal of physiology. Heart and circulatory physiology · 2010
    Article
  18. Article
  19. Endothelial progenitor cells in neovascularization of infarcted myocardium.Journal of molecular and cellular cardiology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ying DaiDepartment of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA.
Muhammad Ashraf
Shi Zuo
Ryota Uemura
Yan-Shan Dai
Yigang Wang
Husnain Kh Haider
Tingyu Li
Meifeng Xu
University of Cincinnati Medical Center · USUniversity of Cincinnati · USChongqing Medical University · CN

Funding

Stem Cells in Cardiac Repair and AngiogenesisR37HL074272 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ASHRAF, MUHAMMAD · 2003 to 2013
$5.7M
Cardiac Repair Using Smart Stem CellsR01HL087246 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ASHRAF, MUHAMMAD · 2007 to 2011
$2.8M
Mechanistic basis of myoblast therapy &angiomyogenesisR01HL080686 · NHLBI · UNIVERSITY OF CINCINNATI · PI ASHRAF, MUHAMMAD · 2005 to 2009
$2.7M
Mitochondrial KATP Channel in CardioprotectionR01HL070062 · NHLBI · UNIVERSITY OF CINCINNATI · PI ASHRAF, MUHAMMAD · 2002 to 2006
$2.5M
Lineage Specific Stem Cell Mobilization for Heart RepairR01HL081859 · NHLBI · UNIVERSITY OF CINCINNATI · PI WANG, YIGANG · 2005 to 2009
$1.9M
Mobilized Stem Cells in Cardiomyogenesis & AngiogenesisR01HL083236 · NHLBI · UNIVERSITY OF CINCINNATI · PI XU, MEIFENG · 2006 to 2010
$1.8M
MYOCARDIAL ISCHEMIC INJURY: MODIFICATION BY DRUG THERAPYR01HL023597 · NHLBI · UNIVERSITY OF CINCINNATI · PI ASHRAF, MUHAMMAD · 1988 to 2003
$1.3M
NHLBI NIH HHS HL080686NHLBI NIH HHS HL081859NHLBI NIH HHS HL083236NHLBI NIH HHS HL087246NHLBI NIH HHS HL23597NHLBI NIH HHS HL70062NHLBI NIH HHS R01 HL023597NHLBI NIH HHS R01 HL070062NHLBI NIH HHS R01 HL080686NHLBI NIH HHS R01 HL081859NHLBI NIH HHS R01 HL083236NHLBI NIH HHS R37 HL074272NHLBI NIH HHS R37-HL074272
6 · The paper itself

Abstract

We proposed here that mobilized progenitor cells (MPCs) from the bone marrow are special cell types which carry cytoprotective proteins for cardiac repair following ischemia. Myocardial ischemia was induced by ligation of the left anterior descending coronary artery (LAD) in mice. Progenitor cells in peripheral blood were analyzed by fluorescence-activated cell sorting (FACS). The expression of cytoprotective genes was assayed by ELISA, RT-PCR, and/or real-time PCR. G-CSF was markedly up-regulated in the ischemic myocardium. A good correlation was observed between serum G-CSF and progenitor cells in circulation following LAD ligation. MPCs overexpressed cardiac transcription factor, GATA-4, and anti-apoptotic factor, Bcl-2, besides expression of the surface markers of bone marrow stem cells (BMSCs). Transplantation of cultured MPCs into the ischemic border area significantly improved cardiac function by reducing infarction size. More importantly, MPCs significantly protected cardiomyocytes against apoptosis when co-cultured with cardiomyocytes. The cardiac protection by MPCs was blocked by Bcl-2 neutralizing antibody and GATA-4 siRNA. In contrast, transfection of BMSCs with GATA-4 provided increased protection of myocytes against apoptosis. It is concluded that MPCs are highly cytoprotective and carry protective genes responsible for cardiac repair.

Indexed as

AnimalsBone Marrow CellsEnzyme-Linked Immunosorbent AssayFlow CytometryGATA4 Transcription FactorGranulocyte Colony-Stimulating FactorMaleMiceMyocardial IschemiaMyocardiumProto-Oncogene Proteins c-bcl-2Reverse Transcriptase Polymerase Chain ReactionStem CellsGATA4 Transcription FactorGranulocyte Colony-Stimulating FactorProto-Oncogene Proteins c-bcl-2

Identifiers

PMID18221754
PMCPMC2685071
OpenAlexW2056000778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.